Vanucizumab is a pioneering bispecific IgG1-like monoclonal antibody designed to concurrently inhibit the interaction of vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2) with their respective receptors. This dual blockade mechanism endows vanucizumab with potent antiangiogenic and anticancer properties, making it an essential tool for research in tumor growth and metastasis inhibition.
Vanucizumab is a pioneering bispecific IgG1-like monoclonal antibody designed to concurrently inhibit the interaction of vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2) with their respective receptors. This dual blockade mechanism endows vanucizumab with potent antiangiogenic and anticancer properties, making it an essential tool for research in tumor growth and metastasis inhibition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
